Logo
B

Biomoneta Research Private Ltd.

Biomoneta develops technology that extract and kill a wide spectrum of microbes (bacteria, fungi and viruses) from contaminated environments. Our novel decontamination technology synergistically patented trapping technology and air-flow design with novel anti-microbial materials to achieve microbial kills of over a billion-fold. Our primary focus is preventing the spread of infections in healthcare settings, where technological support for infection control is not widespread. Hundreds of millions of patients are affected by healthcare-associated infections (HAIs) worldwide each year, leading to significant mortality and financial losses for health systems. Nearly 30% of ICU patients succumb to infections due to poor infection control. The increasing numbers of multidrug organisms make “no-drug” solutions, such as decontamination technologies, an important part of the strategy against HAIs.
Country/AreaIndia
Company Emailsupport@biomoneta.com
IndustryBiotechnologySports & EntertainmentElectrical Equipment & SuppliesMother, Kids & Toys
Company website
Company phone22779 (2021),+91 96067 98427
Established2014
Number of employees1-10
Main Products--
https://www.linkedin.com/company/biomonetahttps://www.instagram.com/avatahome

Business Info

CINU73200KA2014PTC075700
Registered StateKarnataka
Registrar Of CompaniesRoC-Bangalore
CategoryCompany limited by Shares
Sub CategoryNon-govt company
Company ClassPrivate
Company StatusActive
Registered Office AddressEVOMA, Office # 110 - D, #88, Borewell Road, Opposite Whitefield Post office, Whitefield Bengaluru Bangalore KA IN 560066
Authorized Cap2000000.00
Paidup Capital204776.00

Web Summary

Q1: What is the physical address of Biomoneta Research Private Ltd.'s office?
A1: The office address of Biomoneta Research Private Ltd. is Floors 1 and 2, 1401 Railway Parallel Road A Block, Sahakara Nagar, Bangalore 560092 India.

Q2: What type of products does Biomoneta create to prevent the spread of infections in hospitals and other healthcare facilities?
A2: Biomoneta creates solutions to prevent the spread of infections in hospitals and other healthcare facilities through its flagship product, ZeBox, an advanced air decontamination technology that can be used in human presence with zero downtime and low lifetime maintenance.

Q3: What is the industry in which Biomoneta operates?
A3: Biomoneta operates in the healthcare and pharmaceutical industries, specifically in the field of airborne infection control solutions.

Q4: What is the name of Biomoneta's flagship product that can be used in human presence with zero downtime and low lifetime maintenance?
A4: The name of Biomoneta's flagship product is ZeBox, an advanced air decontamination technology that is certified for killing a wide spectrum of airborne pathogens by a nationally accredited lab.

Q5: What was the result of a Department of Biotechnology, Govt of India funded study on the effectiveness of ZeBox against the airborne Covid19 virus?
A5: In the study, ZeBox was shown to be effective in destroying over 10 million virus particles in just 5 minutes.

Q6: Where is ZeBox used in healthcare settings to improve patient safety and reduce risk to doctors and healthcare workers?
A6: ZeBox is used in ICUs, Procedure Rooms, NICUs & Ambulances to improve patient safety and reduce risk to doctors and healthcare workers.

Q7: What type of certification does Biomoneta's ZeBox technology hold?
A7: ZeBox holds a nationally accredited lab certification for killing a wide spectrum of airborne pathogens.

Q8: Is Biomoneta recognized by any industry bodies or awards programs?
A8: Yes, Biomoneta is recognized by multiple industry bodies and awards programs, including the Confederation of Indian Industry, the Association of Biotechnology Led Enterprises, and has been picked as one of India's top startups by FICCI/PwC LevelNxt program and the FICCI/LockheedMartin/Tata Trust program IIGP2.0.

Q9: What is Biomoneta's role in the pharmaceutical and biotechnology industries?
A9: Biomoneta creates solutions to prevent product contamination in critical pharmaceutical and biotechnology environments, helping to mitigate risk of microbial contamination, HAIs, outbreaks, and product recalls.

Q10: Is Biomoneta a CCAMP portfolio company?
A10: Yes, Biomoneta is a CCAMP portfolio company, having been supported by the Governments of India and Karnataka.
Customs Data
As a purchaser
As a Supplier
Disable_icon
Get the Whole details
DisableData_png
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Disable_icon
Get the Whole details
DisableContact_png